JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 24 filers reported holding JASPER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,718,594 | -38.8% | 5,628,558 | 0.0% | 0.89% | -41.6% |
| Q3 2022 | $4,441,000 | -58.3% | 5,628,558 | 0.0% | 1.52% | -55.4% |
| Q2 2022 | $10,638,000 | -45.5% | 5,628,558 | 0.0% | 3.40% | -38.5% |
| Q1 2022 | $19,531,000 | -55.7% | 5,628,558 | 0.0% | 5.54% | -48.2% |
| Q4 2021 | $44,128,000 | -24.0% | 5,628,558 | 0.0% | 10.69% | -18.8% |
| Q3 2021 | $58,030,000 | – | 5,628,558 | – | 13.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 5,852,982 | $20,778,000 | 19.52% |
| Velan Capital Investment Management LP | 3,219,036 | $10,180,000 | 9.45% |
| Abingworth LLP | 5,628,558 | $19,531,000 | 5.54% |
| SECTORAL ASSET MANAGEMENT INC | 675,000 | $2,396,000 | 0.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 540,000 | $1,917,000 | 0.20% |
| Vahanian & Associates Financial Planning Inc. | 10,000 | $36,000 | 0.08% |
| Forefront Analytics, LLC | 32,550 | $118,000 | 0.04% |
| Citadel Advisors | 2,994,580 | $10,631,000 | 0.00% |
| FEDERATED HERMES, INC. | 251,697 | $894,000 | 0.00% |
| Ionic Capital Management LLC | 100 | $0 | 0.00% |